Y-mabs to announce 2022 financial and operating results on march 30, 2023

New york, march 21, 2023 (globe newswire) -- y-mabs therapeutics, inc. (the “company” or “y-mabs”) (nasdaq: ymab) today announced that it will report its financial results for year ended december 31, 2022, on thursday, march 30, 2023, after the close of the u.s. financial markets. the announcement will be followed by a conference call and webcast with the investment community on friday, march 31, 2023, at 9:00 a.m. et. participating on the call from y-mabs will be thomas gad, founder, chairman and interim ceo; bo kruse, chief financial officer; sue smith, chief commerical officer and vignesh rajah, chief medical officer.
YMAB Ratings Summary
YMAB Quant Ranking